![Jessica Newcomb](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 352 992 $ al 31/08/2026
Jessica Newcomb is currently Principal Accounting Officer at Tango Therapeutics, Inc., starting in 2026.
Education includes undergraduate and graduate degrees from Boston College Carroll School of Management.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
TANGO THERAPEUTICS, INC. 0,01 % | 22/09/2026 | 15.455 ( 0,01 % ) | 352 992 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| TANGO THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 15/04/2026 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 1 |
|---|---|
Tango Therapeutics, Inc.
 Tango Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company that engages in discovering and delivering precision cancer medicines | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
